Nanotechnology Now - Press Release: "Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO"

Home > Press > Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO

Abstract:
Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO as of July, 16 2007. Dr. Williams' vast experience and skills will be valuable as Platypus transitions from a start-up to a growth-phase company. Prior to joining Platypus, Dr. Williams served as Senior Vice President and was responsible for product development at Asuragen. Before joining Asuragen, he was Vice President and General Manager of Ambion Diagnostics where he was responsible for the successful commercialization of several FDA-regulated diagnostic products. In addition, Dr. Williams spent over 10 years at Roche Diagnostics where he held several senior level positions, and he was a Vice President at Roche Applied Science during the launch of the LightCycler and many new PCR-based products for life science and diagnostic markets. As a precursor to his time at Roche Applied Science, Dr. Williams was Director of Operations at Roche Molecular Systems and was responsible for the production of all Roche PCR products. Dr. Williams began his career in the bio/pharmaceutical industry at Promega Corporation where he spent six years as Director of Operations. Dr. Williams received both his BS and PhD degrees from the University of Wisconsin-Madison.

Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO

Madison, WI | Posted on July 17th, 2007

####

About Platypus Technologies, LLC
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the analytic and life sciences. The Company offers a variety of nanostructured surfaces for use in research and is also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses advances in nanoscale science, materials science, and molecular biology to provide advanced tools for use in proteomics, cell studies, environmental monitoring and in vitro diagnostics. The Company has 23 employees and is located in the Fitchburg Technology Campus.

For more information, please click here

Contacts:
Dr. Minnie Gupta
Director of Marketing
Ph: 608.237.1270

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: